Core Insights - Sofidel America has ordered a new Advantage ThruAir tissue production line from Valmet to enhance its output of ultra-premium tissue products for the North American market [1][3] - The new production line is designed to produce 75,000 tons annually and is optimized for reduced fiber usage while maintaining paper quality [1] - The project includes advanced automation and digital solutions, such as Valmet DNA control systems and quality monitoring systems [2] Company Developments - Sofidel's CEO, Luigi Lazzareschi, emphasized that this investment strengthens the company's presence in the U.S. and enhances its capacity to meet customer demand [3] - The new line is expected to start up in Q2 of 2028 and is part of Valmet's third quarter 2025 orders received [3] - Sofidel operates 20 tissue lines and has 14 production sites across 11 U.S. states [4] Industry Context - Valmet's executive vice-president, Jon Jested-Rask, described this order as the largest full-scope tissue delivery to date, highlighting advancements in production efficiency and environmental performance [5] - Valmet has secured additional contracts in 2025, indicating a growing demand for automation and quality management solutions in the paper industry [5]